Functional genomics of blood cellular LXR-α gene in human coronary heart disease

Journal of Molecular and Cellular Cardiology

Volumn 46, Issue 4, 2009, Pages 536-544

  Dave, Vivek P ^a   Kaul, Deepak ^a   Sharma, Yashpaul ^a   Bhattacharya, Rajasri ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Blood mononuclear cells; CHD patients; Effector genes; Functional dissection; LXR gene

Indexed keywords

LIVER X RECEPTOR ALPHA; MESSENGER RNA;

ADULT; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DISEASE SEVERITY; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; GENOMICS; HUMAN; ISCHEMIC HEART DISEASE; LIGAND BINDING; LIPID PEROXIDATION; MALE; PRIORITY JOURNAL; SCORING SYSTEM;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; BASE SEQUENCE; BLOOD CELLS; CASE-CONTROL STUDIES; CORONARY DISEASE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENOMICS; HUMANS; LIGANDS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NUCLEIC ACID DENATURATION; ORPHAN NUCLEAR RECEPTORS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RESTRICTION MAPPING; RNA, MESSENGER; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION, GENETIC;

EID: 61449246353     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2008.12.020     Document Type: Article

References (32)

1. Ebrahim S., and Smith G.D. Exporting failure? Coronary heart disease and stroke in developing countries. Int. J. Epidemiol. 30 (2001) 201-205
2. Kutuk O., and Basaga H. Inflammation meets oxidation: NF-kB as a mediator of initial lesion development in atherosclerosis. Trends Mol. Med. 9 (2003) 549-557
3. Ross R. Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 340 (1999) 115-126
4. Saxena U., and Goldberg I.J. Endothelial cells and atherosclerosis: lipoprotein metabolism, matrix interaction and monocyte recruitment. Curr. Opin. Lipidol. 5 (1994) 316-322
5. Joseph S.B., Castrillo A., Laffitte B.A., Mangelsdorf D.J., and Tontonoz P. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat. Med. 9 (2003) 213-219
6. Joseph S.B., McKilligin E., Pei L., Watson M.A., Collins A.R., Laffitte B.A., et al. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. PNAS 99 (2002) 7604-7609
7. Naik S.U., Wang X., Silva J.S., Jaye M., Macphee C.H., and Reilly M.P. Pharmacological activation of liver X receptors promotes reverse cholesterol transport invivo. Circulation 113 (2006) 90-97
8. Baba M.I., Kaul D., and Grover A. Importance of blood cellular genomic profile in coronary heart disease. J. Biomed. Sci. 13 1 (2006) 17-26
9. Kaul D., and Baba M.I. Genomic effect of vitamin 'C' and statins within human mononuclear cells involved in atherogenic process. Eur. J. Clin. Nutr. 59 (2005) 978-981
10. Gensini G.G. A more meaningful scoring system for determining the severity of coronary heart disease. Am. J. Cardiol. 51 (1983) 606-607
11. Boyum A. Ficoll-Hypaque method for separating mononuclear cells and granulaocytes from human blood. Scand. J. Clin. Lab. Invest. 779 (1968) 57-62
12. Chomczynski P., and Sacchi N. Single step method of RNA isolation by acid guanidium thiocynate phenol chloroform extraction. Anal. Biochem. 162 (1987) 156-159
13. Kaul D., Sikand K., and Shukla A.R. Effect of green tea polyphenols on the genes with atherosclerotic potential. Phytotherapy 18 (2004) 177-179
14. Barlic J., Sechler J.M., and Murphy P.M. IL-15 and IL-12 oppositely regulate expression of the chemokine receptor CX3CR1. Blood 102 (2003) 3494-3503
15. Glare E.M., Divjak M., Bailey M.J., and Walters E.H. The usefulness of competitive PCR: airway gene expression of IL-5, IL-4, IL-4d2 and IFN-gamma in asthma. Thorax 26 (2001) 541-548
16. Thompson J.D., Higgins D.G., and Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22 (1994) 4673-4680
17. Marti-Renom M.A., Stuart A., Fiser A., Sa'nchez R., Melo F., and Sali A. Comparative protein structure modeling of genes and genomes. Annu. Rev. Biophys. Biomol. Struct. 29 (2000) 291-325
18. Svensson S., Ostberg T., Jacobsson M., Norstrom C., Stefansson K., Hallén D., et al. Crystal structure of the heterodimeric complex of LXRa and RXRb ligand-binding domains in a fully agonistic conformation. EMBO J. 22 (2003) 4625-4633
19. Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., et al. The Protein Data Bank. Nucleic Acids Res. 28 (2000) 235-242
20. Morris G.M., Goodsell D.S., Halliday R.S., Huey R., Hart W.E., Belew R.K., et al. Automated docking using a Lamarckian genetic algorithm and empirical binding free energy function. J. Comput. Chem. 19 (1998) 1639-1662
21. DeLano W.L. The PyMOL Molecular Graphics System (2002), DeLano Scientific, San Carlos, CA, USA
22. Ishimoto K., Tachibana K., Sumitomo K., Omote S., Hanano I., Yamasaki D., et al. Identification of human low-density lipoprotein receptor as a novel target gene regulated by liver X receptor alpha. FEBS Lett. 580 (2006) 4929-4933
23. Walcher D., Kummel A., Kehrle B., Bach H., Grub M., Durst R., et al. LXR activation reduces proinflammatory cytokine expression in human CD-4 positive lymphocyte. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 1022-1028
24. Srinivasan S., Ranga R.S., Burikhanov R., and Han S.S. Par-4 dependent apoptosis by dietary compound Withaferin A in prostate cancer cells. Cancer Res. 67 (2007) 246-253
25. Chakrabarti P., and Chakrabarti S. C-H⋯O hydrogen bond involving proline residues in α-helices. J. Mol. Biol. 284 (1998) 867-873
26. Kaul D. Molecular link between cholesterol, cytokines and atherosclerosis. Mol. Cell. Biochem. 219 (2001) 65-71
27. Repa J.J., Liang G.J., Bashmakov Y., Labaccaro J.M., Shimomur I., Shan B., et al. Regulation of mouse sterol regulatory element binding protein-1c(SREBP-1c) by oxysterol receptors, LXRα and LXRβ. Genes Dev. 14 (2000) 2819-2830
28. Tontonoz P., and Mangelsdorf D.J. Liver X receptor signaling pathways in cardiovascular disease. Mol. Endocrinol. 17 6 (2003) 985-993
29. Levin N., Bischoff E.D., Daige C.L., Thomas D., Vu C.T., Heyman R.A., et al. Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 135-142
30. Tangirala R.K., Bischoff E.D., Joseph S.B., Wagner B.L., Walczak R., Laffitte B.A., et al. Identification of macrophage liver X receptors as inhibitors of atherosclerosis. PNAS 99 18 (2002) 11896-11901
31. Bensinger S.J., and Tontonoz P. Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature 454 7203 (2008) 470-477
32. Kaul D., Anand P.K., and Khanna A. Functional genomics of PPAR-γ in human immunomodulatory cells. Mol. Cell. Biochem. 290 (2006) 211-215